Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEnterprise ValueEquity AverageEquity RatioInventory AverageInvested CapitalReturn on AssetsReturn on EquityReturn on Sales

Trinity Biotech (TRIB) Asset Utilization Ratio (2016 - 2025)

Historic Asset Utilization Ratio for Trinity Biotech (TRIB) over the last 17 years, with Q2 2025 value amounting to 0.02.

  • Trinity Biotech's Asset Utilization Ratio fell 10319.46% to 0.02 in Q2 2025 from the same period last year, while for Jun 2025 it was 0.02, marking a year-over-year decrease of 10319.46%. This contributed to the annual value of 0.76 for FY2024, which is 86.5% up from last year.
  • According to the latest figures from Q2 2025, Trinity Biotech's Asset Utilization Ratio is 0.02, which was down 10319.46% from 0.61 recorded in Q4 2024.
  • In the past 5 years, Trinity Biotech's Asset Utilization Ratio ranged from a high of 0.92 in Q4 2023 and a low of 0.02 during Q2 2025
  • Its 5-year average for Asset Utilization Ratio is 0.7, with a median of 0.74 in 2023.
  • In the last 5 years, Trinity Biotech's Asset Utilization Ratio skyrocketed by 4038.06% in 2023 and then plummeted by 10319.46% in 2025.
  • Quarter analysis of 5 years shows Trinity Biotech's Asset Utilization Ratio stood at 0.77 in 2021, then decreased by 14.46% to 0.66 in 2022, then skyrocketed by 40.38% to 0.92 in 2023, then tumbled by 33.61% to 0.61 in 2024, then crashed by 103.31% to 0.02 in 2025.
  • Its Asset Utilization Ratio was 0.02 in Q2 2025, compared to 0.61 in Q4 2024 and 0.62 in Q3 2024.